Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Essential Hypertension”

80 trials

Showing 20 of 80 results

Large-scale testing (Phase 3)Study completedNCT01701726
What this trial is testing

Effect of Acupuncture on Patients With Mild Hypertension

Who this might be right for
Essential Hypertension
Chengdu University of Traditional Chinese Medicine 400
Post-approval studies (Phase 4)Study completedNCT00333489
What this trial is testing

Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension

Who this might be right for
Hypertension
Novartis 551
Large-scale testing (Phase 3)Study completedNCT01672476
What this trial is testing

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 293
Testing effectiveness (Phase 2)Study completedNCT03756103
What this trial is testing

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Who this might be right for
Hypertension,Essential
Shanghai Pharmaceuticals Holding Co., Ltd 120
Post-approval studies (Phase 4)Study completedNCT02031861
What this trial is testing

Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shanghai Shyndec Pharmaceutical Co., Ltd. 38
Large-scale testing (Phase 3)Study completedNCT02177331
What this trial is testing

Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 53
Testing effectiveness (Phase 2)Study completedNCT00923611
What this trial is testing

Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 182
Testing effectiveness (Phase 2)Study completedNCT00922441
What this trial is testing

A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 92
Large-scale testing (Phase 3)Study completedNCT01135212
What this trial is testing

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 290
Large-scale testing (Phase 3)UnknownNCT06141200
What this trial is testing

NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial

Who this might be right for
Essential Hypertension
Natural Wellness Egypt 286
Large-scale testing (Phase 3)Study completedNCT01001572
What this trial is testing

Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Novartis 932
Testing effectiveness (Phase 2)Study completedNCT00374855
What this trial is testing

A Study in People With Mild Hypertension

Who this might be right for
Mild Hypertension
Eli Lilly and Company 153
Large-scale testing (Phase 3)Study completedNCT00257491
What this trial is testing

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 29
Large-scale testing (Phase 3)Study completedNCT00236665
What this trial is testing

Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
ObesityHypertension
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 531
Large-scale testing (Phase 3)Study completedNCT02466490
What this trial is testing

Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension

Who this might be right for
Hypertension, Essential
Stendhal Americas, S.A. 272
Early research (Phase 1)Not Yet RecruitingNCT07152444
What this trial is testing

A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension

Who this might be right for
Uncontrolled Hypertension
Qilu Pharmaceutical Co., Ltd. 78
Large-scale testing (Phase 3)Study completedNCT00139698
What this trial is testing

Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Pfizer 410
Large-scale testing (Phase 3)Study completedNCT05359068
What this trial is testing

Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shanghai Pharmaceuticals Holding Co., Ltd 957
Testing effectiveness (Phase 2)Ended earlyNCT01373086
What this trial is testing

LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

Who this might be right for
Hypertension
Novartis Pharmaceuticals 19
Testing effectiveness (Phase 2)Study completedNCT00701649
What this trial is testing

Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of a Vaccine Against Essential Hypertension

Who this might be right for
Hypertension
Cytos Biotechnology AG 60
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation